Sole Source Procurement Notice

The United States Department of Agriculture (USDA)/Animal Plant Health Inspection Services (APHIS) intends to award a sole source contract to Medivet Pharmaceuticals Ltd., Alberta, Canada for three hundred-ninety (390) bottles (454 g/bottle) of Fumagilin-B. The supply of Fumagilin-B is an antibiotic used by the Plant Protection and Quarantine (PPQ) - Pink Bollworm Rearing Facility (PBWRF) located in Phoenix, AZ for use to prevent the establishment of Nosema in its mass reared colony of pink bollworms. To the best of our knowledge, Medivet Pharmaceuticals Ltd. is the sole manufacturer and direct distributor of Fumagilin-B in North America. Accordingly, this procurement is being conducted in accordance FAR 6.302-1 (only one responsible source and no other supplies or services will satisfy the agency requirements). Contract is firm fixed price. The North American Industry Classification System (NAICS) code for this acquisition is 325998, and the size standard is 500. This Notice of Intent is not a request for competitive proposals. No solicitations documents are available and telephone requests will not be honored. However, if a firm believes it can meet the requirements it must furnish information about its products, as well as three (3) references from other customers who are using these products to the Contracting Officer by 3:30 p.m. Central Time (CT) on Wednesday, January 28, 2009. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Responses received after the response date or without the required information will be deemed nonresponsive to the synopsis and will not be considered. Capability statements may be sent to: Daniel M. Kline, Contracting Specialist, USDA-APHIS-MRPBS, ASD Procurement Branch, Butler Square Building, 5th Floor, 100 N. 6th Street, Minneapolis, MN 55403, or via email @ [email protected] or fax @ (612) 336-3550. Responses received will be evaluated however; a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, APHIS will proceed with the sole source procurement with Medivet Pharmaceuticals Ltd.